Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02210299
Other study ID # 35RC13_8917_TEXTO
Secondary ID 2014-A00782-4514
Status Withdrawn
Phase N/A
First received August 5, 2014
Last updated June 9, 2015
Start date September 2014
Est. completion date May 2015

Study information

Verified date June 2015
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

People are, especially in industrialized countries, exposed to a growing number of ubiquitous chemical substances. It thus increases human exposure pathways: diet, inhalation, soil and dust dermal contact…), notably for semi-volatile organic compounds. Diet is generally sought to contribute the most to total exposure for many chemicals, the relative contribution of each pathway is nevertheless poorly described, and can be different among populations. This is in particularly the case For young children, who can be more exposed via the environment, because of frequent contact with object and dust and hand to mouth behaviors. Children are in addition considered more sensitive to chemical risk due to their maturating systems.

In this context, the objective of this project is to characterize the young children's exposure to a particular class of semi volatile organic compounds. It will encompass the relative contribution of different pathways to the external dose, and to try to match the internal and external doses with a physiologically based pharmacokinetic (PBPK) model for molecules for which it is possible.

The present demand concerns a feasibility study on 2 children, for Perfluorinated Alkylated Substances (PFAS), used in numerous consumer products.


Description:

Pilot study for testing feasibility of cross sectional integrative exposure study.

Strategy : Exposure assessment of young children to PFAS with simultaneous measurement of internal (serum) and external doses (diet, indoor environment: contamination data and human exposure factors; quantity ingested and breathed).

Expected outcomes :

Assessment of feasibility to obtain:

- original data on children's body burden

- original contamination data for food, water, air and dust ;

- Matching of these data to identify main sources and pathways of exposure.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 6 Months to 18 Months
Eligibility Inclusion Criteria:

Young children (2-6 months ; 12-18 months)

- In outpatient pediatric or pediatric surgery ;

- From their homes ;

- With home located less than 30km from Rennes ;

- Living at their home (not at childcare facility or child-minder);

- With a scheduled blood sampling apart from this study ;

- For child 2 - 6 months :

- With diet exclusively based on milk (maternal exclusively or commercial exclusively)

- In case of breastfeeding, with mother accepting milk sampling ;

- With a free, enlightened and signed written consent from the parents.

Breastfeeding mother :

- > 18 years ;

- Exclusive breastfeeding ;

- With a free, enlightened and signed written consent.

Exclusion Criteria:

Children :

- Metabolic illness ;

- Renal or hepatic insufficiency ;

- Malabsorption

- With known HIV+, HBV+, HCV+, CMV+ serology

- Simultaneously participating to other biomedical survey

For breastfeeding mother :

- Under legal protection (judicial protection, guardianship) ;

- mixed breastfeeding ;

- with Known HIV+, HBV+, HCV+, CMV+ serology

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Exposure study
Sampling of blood, food, water, air and dust and delivery of dietary questionnaire

Locations

Country Name City State
France Rennes Hospital University Rennes Brittany

Sponsors (5)

Lead Sponsor Collaborator
Rennes University Hospital Agence Nationale de Sécurité Sanitaire de l'alimentation de l'Environnement et du Travail, Institut de Recherche en Santé, Environnement et le Travail, France, Institut National de l'Environnement Industriel et des Risques, Laboratoire d'Etude des Résidus et Contaminants dans les Aliments

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility recruitment Main objective of this feasibility study is to set the scientific consortium to recruit and study 2 young children's exposures.
Main judgement criteria : Effective enrolment of 2 young children during their consultation to Rennes hospital, from those having a blood sampling for medical purposes, and house survey.
3 months No
Secondary Protocol validation Second objective is to validate protocols, procedures and methods to study exposure to PFAS.
Secondary judgment criteria :
Possibility to sample an extra volume of blood, to prepare it and transport it at -18°C to Laberca lab, Nantes;
Possibility to organize a home visit with sampling of diet, water, air, dust and delivery of dietary questionnaire;
Possibility to quantify PFAS in dietary and environmental samples;
Possibility to model the internal dose for some compounds from kinetics data, and to compare doses estimated from blood measurements to those from environmental and diet measurements
1 year No
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1